Deok Yong Sim

688 citations
39 papers · 497 indexed · h-index 15
Topics
Cancer-related Molecular Pathways (6 papers)Bioactive Compounds and Antitumor Agents (4 papers)Genomics, phytochemicals, and oxidative stress (4 papers)
Partner nations
South KoreaUnited States

In The Last Decade

Deok Yong Sim

39 papers receiving 493 citations

Peers

Deok Yong Sim
Comparison fields: 5 of 73
  • Molecular Biology 332
  • Cancer Research 123
  • Oncology 100
  • Immunology 57
  • Epidemiology 48
Replace Ji Eon Park with:
Ji Eon Park South Korea
Jie Wei China
Yunlong Shan China
Ju‐Ha Kim South Korea
Jianlin Ren China
Devaraja Rajasekaran United States
Han‐Tsang Wu Taiwan
Yukai Xiang China
Ghader Babaei Iran
Haiyan Sun China
Deok Yong Sim relative to Ji Eon Park South Korea Ji Eon Park's profile →
Citations per field
00.5×1.5×
Ji Eon Park · 1×
Citations per year

Countries citing papers authored by Deok Yong Sim

Since Specialization
Citations

This map shows the geographic impact of Deok Yong Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deok Yong Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deok Yong Sim more than expected).

Fields of papers citing papers by Deok Yong Sim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deok Yong Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deok Yong Sim. The network helps show where Deok Yong Sim may publish in the future.

Co-authorship network of co-authors of Deok Yong Sim

This figure shows the co-authorship network connecting the top 25 collaborators of Deok Yong Sim. A scholar is included among the top collaborators of Deok Yong Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deok Yong Sim. Deok Yong Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 3
3 4
4 14
5 1
6 7
7 6
8 7
9 8
10 5
11 4
12 2
13 12
14 34
15 7
16 15
17 31
18 27
19 13
20 15

About Deok Yong Sim

Deok Yong Sim is a scholar working on Toxicology, Pharmacology and Cancer Research, having authored 39 papers that have together received 497 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Cancer Research (123 citations), Molecular Biology (332 citations) and Pharmacology (34 citations). Deok Yong Sim has collaborated with scholars based in South Korea and United States. Frequent co-authors include Sung‐Hoon Kim, Hyo‐Jung Lee, Ji Eon Park, Ji Hoon Jung, Eunji Im, Bum Sang Shim, Ju‐Ha Kim, Bonglee Kim, Hyemin Lee and Bum‐Sang Shim. Their work appears in journals such as International Journal of Molecular Sciences, Antioxidants and Redox Signaling and Seminars in Cancer Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026